Surprised these didn’t warrant a separate announcement.
There’s a few pretty exciting things mentioned:
• Oraline has reached new prototype stage and the prototypes were successful
• The company is exploring genomic and genetic testing using its existing IP
• The company is exploring hand-held electronic drugs testing devices, using its existing IP
As well as the above, the company confirmed it continues to look at other opportunities in therapeutics.
IMO Excellent.
- Forums
- ASX - By Stock
- SBN
- new info in half yearly report
new info in half yearly report
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online